According to the research report, the global medicalaffairs outsourcing market size is expected to touch USD 4.28 Billion by 2030, from USD 1.55 Billion in 2021, growing with a significant CAGR of 12.2% from 2022 to 2030.
The medical affairs outsourcing market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global medical affairs outsourcing market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global medical affairs outsourcing market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global medical affairs outsourcing market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1113
| Report Highlights | Details |
| Market Size | US$ 4.28 billion by 2030 |
| Growth Rate | CAGR of 12.2% From 2022 and 2030 |
| Base Year | 2021 |
| Historic Data | 2017 to 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | By Services, By Industry and Regional |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
| Companies Mentioned | ICON plc, Wuxi Clinical Development, I |
This study covers a detailed segmentation
of the global medical affairs outsourcing market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global medical affairs outsourcing market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- ICON plc
- Wuxi Clinical Development, Inc
- Pharmaceutical Product Development, LLC
- Ashfield Healthcare Communications
- Indegene Inc.
- IQVIA Holdings Inc
- The Medical Affairs Company (TMAC)
- SGS SA
- Syneos Health Inc
- ZEINCRO Group
Market Segmentation
- Medical Monitoring
- Medical Writing & Publishing
- Medical Information
- Medical Science Liaisons
- Others
By Industry
- Medical Devices
- Pharmaceutical
- Biopharmaceutical
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Research Methodology
The research methodology adopted by
analysts for compiling the global medical affairs outsourcing market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global medical affairs outsourcing market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Affairs Outsourcing Market, By Services
7.1. Medical Affairs Outsourcing Market, by Services Type, 2021-2030
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Medical Affairs Outsourcing Market, By Industry
8.1. Medical Affairs Outsourcing Market, by Industry, 2021-2030
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)
Chapter 10. Company Profiles
10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments